4 min read

Best Practices in REMS & the Importance of Stakeholder Feedback

Find out why optimal REMS program design includes taking in and incorporating feedback from all involved stakeholders.

Contributors

Jenn Lundmark

Jenn Lundmark serves as a Director of REMS Project Management for UBC. In this role, Jenn is responsible for the operational implementation and ongoing oversight of REMS with ETASU programs. Jenn joined UBC in 2021 and has more than 13 years’ experience in the patient access and Risk Evaluation and Mitigation (REMS) industry.

The timing of planning for a Risk Evaluation and Mitigation Strategy (REMS) varies, but considering all stakeholders once you begin planning is critical. This can include direct feedback from stakeholders to ensure a successful launch without needing immediate revisions. When planning a REMS program, it is important to solicit feedback from stakeholders including patients, healthcare providers (HCPs), and pharmacists prior to REMS tool design.

Key strategies to ensure success include:

  • Starting REMS planning early
  • Obtaining stakeholder feedback from Key Opinion Leaders
  • Considering timeline implications
  • Evaluating plans and procedures to determine feasibility
  • Consulting the FDA REMS Website for guidance
  • Factoring in stakeholder characteristics in planning and tool design

When soliciting stakeholder feedback, consider whether a qualitative or quantitative approach is best.  An overview of qualitative and quantitative research approaches are listed below.

Qualitative ResearchQuantitative Research
Smaller sample size/non-representative of the entire populationLarger sample size/can be generalized to cover the entire population
Unstructured data collectionStructured data collection
Gives an open space to explore topics or areas of focusSurveys with closed-ended questions (KABs)
Allows for updating questions and follow-ups in real timeClosed-ended questions that can be analyzed with numerical and statistical methods
Observe and interpretMeasure and test
Grouping of common data/non-statistical analysisStatistical analysis
Research methodology is exploratoryResearch methodology is often conclusive

Some tips and best practices in getting the best feedback from stakeholders include:

  • Evaluating different designs or layout options of tools or materials
  • Evaluating patient materials with HCPs to ensure consistent messaging
  • Testing alternative wording or language to evaluate comprehension
  • Evaluating stakeholder feedback in real-time – does the plan match the reality?
  • Considering the burden to HCPs and patients and developing questions to identify areas of pain points

UBC is the leading provider of risk management and REMS services. Our REMS consultation, design, and implementation aim to reduce stakeholder burden, minimize barriers to access, and ensure product safety and value. To learn more about optimal design and implementation of REMS programs, click here, or contact us here to discuss your REMS needs with one of our experts.

About the Authors

Jenn Lundmark serves as a Director of REMS Project Management for UBC. In this role, Jenn is responsible for the operational implementation and ongoing oversight of REMS with ETASU programs. Jenn joined UBC in 2021 and has more than 13 years of experience in the patient access and Risk Evaluation and Mitigation (REMS) industry.

Marita Lynott is the Associate Director of Patient & Physician Services at UBC. She has more than 20 years of experience in clinical research and healthcare communications. Ms. Lynott manages a team of graphic designers all focused on designing Risk Evaluation & Mitigation Strategy (REMS) materials for various stakeholders. She leads all Qualitative Research programs ensuring that stakeholder feedback is incorporated into the design of REMS materials and Knowledge, Attitude, and Behavior (KAB) surveys.

Other Recent Posts

Press
5 min read

UBC Successfully Implemented REMS Administration Software DuringHL7® FHIR® Connectathon

UBC demonstrated our commitment to optimizing safe medication use and health outcomes by participating in the HL7® FHIR® Connectathon.
Press
5 min read

UBC Selects Oracle Cloud Safety Technology for its Safety Programs

UBC selected Oracle Life Sciences' safety case management solution.
Press
2 min read

UBC Receives CRO Leadership Award Again

UBC was honored as a winner in the 2023 CRO Leadership Awards by both big and small pharma in the Reliability category.

Thank You for Connecting with UBC

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

What You Can Expect Next

Lorem ipsum dolor sit amet consectetur. Cras aliquam erat eget magna sollicitudin.

Get Ready to Change Your Business

Lorem ipsum dolor sit amet consectetur. Mi proin enim ipsum nascetur. Venenatis odio scelerisque non netus ac et pellentesque.

Service Request

Bekki Bracken Brown

President & Chief Executive Officer

Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.

With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.